Terms: = Lung cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846
224 results:
1. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Li ZM; Liang ZH; Liu N; Wei KR
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
[No Abstract] [Full Text] [Related]
2. [cancer incidence and mortality in China, 2022].
Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
[No Abstract] [Full Text] [Related]
3. lung cancer outcomes in the elderly: potential disparity in screening.
Singh A; Mazzola E; Xie Y; Marshall MB; Jaklitsch MT; Wilder FG
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38445715
[TBL] [Abstract] [Full Text] [Related]
4. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
5. Pulmonary salivary gland tumor-hyalinizing clear cell carcinoma: a literature review.
Wang X; Hu S; Lu H
Diagn Pathol; 2024 Feb; 19(1):37. PubMed ID: 38389101
[TBL] [Abstract] [Full Text] [Related]
6. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?
Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma.
Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z
Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821
[TBL] [Abstract] [Full Text] [Related]
8. Smoking, Drinking, and Dietary Risk Factors for Head and Neck cancer in Prostate, lung, Colorectal, and Ovarian cancer Screening Trial Participants.
Lander DP; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):249-256. PubMed ID: 38329760
[TBL] [Abstract] [Full Text] [Related]
9. Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.
Hung YP; Chirieac LR
Arch Pathol Lab Med; 2024 May; 148(5):e77-e89. PubMed ID: 38190277
[TBL] [Abstract] [Full Text] [Related]
10. Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Hong J; Lee J; Park S; Jung HA; Sun JM; Lee SH; Ahn JS; Sinn DH; Ahn MJ
Cancer; 2024 May; 130(9):1693-1701. PubMed ID: 38165808
[TBL] [Abstract] [Full Text] [Related]
11. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract] [Full Text] [Related]
12. Clinical, Genomic, and Transcriptomic Featurses of lung Adenocarcinoma With Uncommon EGFR Mutation.
Hayasaka K; Takeda H; Sakurada A; Matsumura Y; Abe J; Shiono S; Notsuda H; Suzuki H; Endo M; Motohashi H; Okada Y
Clin Lung Cancer; 2024 Jan; 25(1):e43-e51. PubMed ID: 37985312
[TBL] [Abstract] [Full Text] [Related]
13. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract] [Full Text] [Related]
14. Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study.
Manninen O; Puuniemi L; Iivanainen S; Arffman M; Kaarteenaho R; Koivunen JP
Acta Oncol; 2023 Dec; 62(12):1854-1861. PubMed ID: 37934101
[TBL] [Abstract] [Full Text] [Related]
15. Mesothelioma Risk Among Maritime Workers According to Job Title: Data From the Italian Mesothelioma Register (ReNaM).
Vimercati L; Cavone D; Negrisolo O; Pentimone F; De Maria L; Caputi A; Sponselli S; Delvecchio G; Cafaro F; Chellini E; Binazzi A; Di Marzio D; Mensi C; Consonni D; Migliore E; Brentisci C; Martini A; Negro C; D'Agostin F; Grappasonni I; Pascucci C; Benfatto L; Malacarne D; Casotto V; Comiati V; Storchi C; Mangone L; Murano S; Rossin L; Tallarigo F; Vitale F; Verardo M; Eccher S; Madeo G; Staniscia T; Carrozza F; Cozzi I; Romeo E; Pelullo P; Labianca M; Melis M; Cascone G; Ferri GM; Serio G
Med Lav; 2023 Oct; 114(5):e2023038. PubMed ID: 37878258
[TBL] [Abstract] [Full Text] [Related]
16. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
[TBL] [Abstract] [Full Text] [Related]
17. Causal relationship between lung diseases and risk of esophageal cancer: insights from Mendelian randomization.
Zhou J; Fang P; Liang Z; Li X; Luan S; Xiao X; Gu Y; Shang Q; Zhang H; Yang Y; Chen L; Zeng X; Yuan Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15679-15686. PubMed ID: 37665406
[TBL] [Abstract] [Full Text] [Related]
18. Second Primary cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptome Analysis of the Inhibitory Effects of 20(S)-Protopanaxadiol on NCI-H1299 Non-Small Cell lung cancer Cells.
Cong Z; Zhang X; Lv Z; Jiang J; Wang L; Li J; Wang J; Zhao J
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570716
[TBL] [Abstract] [Full Text] [Related]
20. Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review.
Li Z; Li W; Xue L
Diagn Pathol; 2023 Aug; 18(1):90. PubMed ID: 37553667
[TBL] [Abstract] [Full Text] [Related]
[Next]
